Pyrazoloacridine

DB12549InvestigationalSmall molecule

Pyrazoloacridine has been used in trials studying the treatment of Lung Cancer, Liver Cancer, Breast Cancer, Melanoma (Skin), and Metastatic Cancer, among others.

Chemical structure of Pyrazoloacridine
Formula / weight
C19H21N5O3 · 367.409 g/mol (avg)
Code names
PD-115934

Resolves to

Compound
UNIIL24XJN68OWCAS99009-20-8ChEMBLCHEMBL118841PubChem5351360
Structure
InChIKeyHZCWPKGYTCJSEB-UHFFFAOYSA-NSMILESCOC1=CC=C2NC3=C4C(=CC=C3[N+]([O-])=O)N(CCCN(C)C)N=C4C2=C1
Targets
Q02880TOP2BP11388TOP2A

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pyrazoloacridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In